The Influence of Lifestyle Behaviors and Body Mass Index Changes on Long-term Outcomes After Gastric Cancer Surgery: A Population-Based Cohort Study
- PMID: 40200878
- PMCID: PMC11982505
- DOI: 10.5230/jgc.2025.25.e18
The Influence of Lifestyle Behaviors and Body Mass Index Changes on Long-term Outcomes After Gastric Cancer Surgery: A Population-Based Cohort Study
Abstract
Purpose: The present study investigated the impact of lifestyle behaviors and body mass index (BMI) on late recurrence, gastric remnant cancer (GRC), and long-term survival after curative gastrectomy.
Materials and methods: This retrospective study utilized data from the Korean National Health Insurance claims database. Among 71,014 patients with gastric cancer who underwent curative gastrectomy between January 2009 and December 2012, 23,359 remained cancer-free for five years. Of these, 7,735 patients with health examination data within 2 years before surgery and 5 years after surgery were analyzed for lifestyle behaviors, including smoking, alcohol consumption, and physical activity. Multivariable analysis was used to evaluate the independent effects of these factors and changes in BMI on late recurrence, GRC, and long-term survival.
Results: Late recurrence or GRC occurred among 628 patients (8.1%). Older age (≥60 years) and total gastrectomy were identified as risk factors. Although lifestyle behaviors and BMI changes did not directly affect recurrence, they significantly affected mortality. In the total gastrectomy group, current underweight status (hazard ratio [HR], 1.586) was associated with increased mortality. Among the partial gastrectomy group, continued smoking (HR, 1.366) and current underweight status (HR, 1.915) increased mortality risk. Conversely, regular physical activity (starting: HR, 0.674; continuing: HR, 0.699) and postoperative overweight or obesity (BMI >25 kg/m²) (HR, 0.713) were associated with reduced mortality. Changes in alcohol consumption showed inconsistent effects between the partial and total gastrectomy groups.
Conclusions: The long-term survival of post-gastrectomy patients improved with smoking cessation, regular physical activity, and maintenance of body weight.
Keywords: Body mass index; Gastric cancer; Late recurrence or gastric remnant cancer; Lifestyle behaviors; Long-term survival.
Copyright © 2025. Korean Gastric Cancer Association.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures


Similar articles
-
Lifestyle factors and long-term survival of gastric cancer patients: A large bidirectional cohort study from China.World J Gastroenterol. 2020 Apr 14;26(14):1613-1627. doi: 10.3748/wjg.v26.i14.1613. World J Gastroenterol. 2020. PMID: 32327910 Free PMC article.
-
Association of lifestyle modification with the development of cardiovascular disease in gastric cancer patients who underwent gastrectomy: A nationwide population-based study.Cancer Med. 2024 Jul;13(14):e70038. doi: 10.1002/cam4.70038. Cancer Med. 2024. PMID: 39046111 Free PMC article.
-
Lower risk of depression after smoking cessation and alcohol abstinence in patients with gastric cancer who underwent gastrectomy: A population-based, nationwide cohort study.Cancer. 2023 Sep 15;129(18):2893-2903. doi: 10.1002/cncr.34849. Epub 2023 May 17. Cancer. 2023. PMID: 37195133
-
Does high body mass index negatively affect the surgical outcome and long-term survival of gastric cancer patients who underwent gastrectomy: A systematic review and meta-analysis.Eur J Surg Oncol. 2018 Dec;44(12):1971-1981. doi: 10.1016/j.ejso.2018.09.007. Epub 2018 Oct 16. Eur J Surg Oncol. 2018. PMID: 30348605
-
Impact of Lifestyle Modifications on Cancer Mortality: A Systematic Review and Meta-Analysis.Medicina (Kaunas). 2025 Feb 10;61(2):307. doi: 10.3390/medicina61020307. Medicina (Kaunas). 2025. PMID: 40005424 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810–1820. - PubMed
-
- Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379:315–321. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical